Background:

Contraceptive methods have been shown to be effective in avoiding pregnancy and improving individual agency in family planning. They also show promise as a therapeutic intervention for disorders related to menstruation. Research now available indicates that endometriosis, uterine fibroids, excessive menstrual flow, painful menstruation, atypical and extended uterine bleeding, and premenstrual dysphoric syndromes can all be adequately treated with contraceptives. Examining the extra advantages of contraceptives for menstruation individuals is crucial, especially considering how widely accepted and easily accessible they are in clinical practice for preventing pregnancy.

Objectives:

In-depth analysis of the effects of long-acting reversible contraceptives (such as implants and intrauterine devices), condoms, and birth control tablets on menstrual health is the goal of this review.

Methods:

A comprehensive search was carried out over ten databases between their creation.
The following types of study designs were accepted: controlled clinical trials, cohort or longitudinal analyses, interrupted time series studies, controlled before and after investigations, parallel or cluster randomized controlled trials, and case-control studies. Furthermore, only research that included a control group that abstained from using contraceptives as a comparison group was taken into consideration.
Papers having a Kappa score higher than seven were screened in pairs by ten members of the team. Using Covidence, abstracts (stage 1) and complete articles (stage 2) were separately examined. Disagreements were settled through dialogue. During the comprehensive article review process, reviewers were tasked with gathering data from qualifying research.

Results:

Endometriosis, uterine fibroids, excessive menstrual flow, painful menstruation, abnormal and extended uterine bleeding, and premenstrual dysphoric syndromes were among the ailments for which hormonal contraceptives emerged as well-tolerated, non-invasive, and clinically successful therapies. Research evaluating the well-being or quality of life in women suffering from endometriosis, uterine fibroids, or excessive monthly flow revealed improvements in every parameter examined.

Conclusions:

Hormonal contraceptives relieve severe discomfort, lessen the intensity of symptoms, and restore normal flow patterns in cases of endometriosis, uterine fibroids, and excessive menstrual bleeding. Ongoing studies on the various advantages of hormonal components and dosages on non-reproductive health have the potential to guide clinical practice as new contraceptive techniques continue to be developed.